semaglutide effect on dopamine drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons Semaglutide reduces alcohol intake and

History of pancreatitis: Semaglutide GLP-1 may increase the risk of pancreatitis

A higher-dose version Wegovy HD (7.2 mg) was recently approved in April 2026 with weight loss results closer to 18.7%

How Semaglutide May Contribute to Palpitations Semaglutide affects the body in several ways that could lead to heart palpitations: Changes in Blood Sugar This medication lowers blood sugar levels, which can sometimes cause hypoglycemia (low blood sugar)

People who were hospitalized due to gastroparesis or bowel obstruction, who were diagnosed with NAION vision loss, ileus or pancreatitis, or who experienced pulmonary aspiration during surgery or while under anesthesia after using Ozempic, Wegovy, Saxenda, Victoza, or Mounjaro may be eligible for compensation